| The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease. | |
| | |
MedLine Citation:
|
PMID: 12964969 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
C-reactive protein (CRP) levels have not been routinely used to diagnose thyroid disease, although many thyroid conditions involve inflammation. This study was intended to determine whether CRP levels could differentiate between inflammatory and noninflammatory thyroid conditions, especially between type II inflammatory amiodarone-induced thyrotoxicosis (AIT) and type I iodine-induced AIT. Serum high-sensitivity CRP levels were measured in 100 euthyroid controls (7 taking amiodarone) and 353 patients with one of the following thyroid conditions: AIT, subacute thyroiditis, toxic diffuse goiter, nodular goiter, Hashimoto's thyroiditis, shortterm hypothyroidism, or postpartum thyroiditis. No patients with nontoxic multinodular goiter (n = 34), toxic nodular goiter (n = 23), or toxic diffuse goiter, either untreated (n = 49) or euthyroid while taking methimazole (n = 33), had positive CRP levels (>10 mg/L). The occurrence of positive CRP levels among patients with Hashimoto's thyroiditis (n = 35), short-term hypothyroidism (n = 38), and postpartum thyroiditis (n = 70) did not differ significantly from controls. The occurrence of positive CRP values did not differ significantly between patients with type I and type II AIT and controls. Six of 7 patients (86%) with untreated subacute thyroiditis had positive CRP levels (p < 0.00001). These results indicate that there is only a limited role for measurement of CRP levels in the diagnosis of thyroid diseases other than subacute thyroiditis. |
| | |
Authors:
|
Elizabeth N Pearce; Fausto Bogazzi; Enio Martino; Sandra Brogioni; Enia Pardini; Giovanni Pellegrini; Arthur B Parkes; John H Lazarus; Aldo Pinchera; Lewis E Braverman |
Related Documents
:
|
10781659 - Power doppler sonography in the diagnosis of graves' disease. 9006429 - Secondary squamous cell carcinoma of the orbit. 15272239 - Molecular technology and the recombinant tsh have changed diagnostics of thyroid carcin... 20407389 - Primary antiphospholipid syndrome and thyroid involvement. 1573949 - Ultrasonography for the diagnosis of lyme disease in cases of acute facial paralysis. 22617359 - Celiac disease and giardiasis: a case report. 15958359 - Heart failure with preserved left ventricular systolic function: a hospital cohort study. 17268399 - Linkage of elevated caxpo4 product with inflammation in maintenance hemodialysis patients. 3149149 - Juvenile galactosialidosis in a white male: a new variant. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Thyroid : official journal of the American Thyroid Association Volume: 13 ISSN: 1050-7256 ISO Abbreviation: Thyroid Publication Date: 2003 Jul |
Date Detail:
|
Created Date: 2003-09-10 Completed Date: 2004-04-01 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 9104317 Medline TA: Thyroid Country: United States |
Other Details:
|
Languages: eng Pagination: 643-8 Citation Subset: IM |
Affiliation:
|
Section of Endocrinology, Diabetes, and Nutrition, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts 02118, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Amiodarone / adverse effects Anti-Arrhythmia Agents / adverse effects C-Reactive Protein / metabolism* Case-Control Studies Diagnosis, Differential Female Humans Male Middle Aged Thyroid Diseases / blood*, diagnosis* Thyroiditis / blood*, diagnosis* Thyrotoxicosis / blood, chemically induced, classification, diagnosis |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Arrhythmia Agents; 1951-25-3/Amiodarone; 9007-41-4/C-Reactive Protein |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Evidence and thoughts about thyroid nodules that grow after they have been identified as benign by a...
Next Document: The effect of short-term treatment with recombinant human thyroid-stimulating hormones on leydig cel...